Home › Cancer (all types) › NCT07743476
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
RecruitingObservational study
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria * Diagnosis of a hematologic, oncologic, or other condition relevant to the study. * Availability of clinical, imaging, laboratory, treatment, and/or outcome data relevant to the study. * Ability to provide informed consent for prospective participation or, for pediatric participants, parent/legal guardian permission with assent when applicable. * Participants undergoing research MRI must be eligible for MRI according to institutional safety requirements. Exclusion Criteria * Inability to provide required informed consent or parental/legal guardian permission for prospective participation. * Insufficient clinical information to support study participation * Pregnancy. * Contraindication to MRI will exclude participants from research-specific MRI but not necessarily from other study components.
About the study
An observational study of patients with hematologic, oncologic, and other relevant conditions undergoing bone marrow imaging, with longitudinal collection of imaging, treatment, and clinical outcome data to characterize bone marrow features and changes over time
What is being tested
- Data Collection (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 1,000 · Started: Aug 31, 2026
Contact the study team
- Omran Saifi, MD · Phone: 832-829-0337
Official record on ClinicalTrials.gov — NCT07743476
Locations in the U.S.
| Texas | UT MD Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.